The NIH is facing significant reform proposals from both Congress and the incoming administration, aiming to reshape its US$47-billion research portfolio amidst increased scrutiny.
Jennifer Zeitzer highlights the urgency and competition among congressional members and the NIH to determine the future direction of the agency amid reform discussions.
Legislative proposals emerge as bipartisan efforts, driven by concerns over NIH's handling of COVID-19 and its oversight of risk-prone research, signaling a directive for change.
With Republicans controlling Congress and the White House, there’s a notable increase in proposals to alter the structure and operational capacity of the NIH.
Collection
[
|
...
]